Massachusetts General Hospital

Biden’s Pick for CDC Director Hailed for Gender Equity Commitment

Rochelle Walensky, who heads the infectious disease unit at Massachusetts General Hospital, will shape how the government distributes coronavirus vaccines.

Rochelle Walensky, who will head the Centers for Disease Control and Prevention under President-elect Joe Biden, has emerged over the past year as one of the nation’s foremost experts on managing the pandemic. Her selection, announced Monday, could signal a sharper government focus on gender inequities and vulnerable populations when it comes to rolling out COVID-19 vaccines.

Unlike other senior level advisers, the CDC director does not require Senate confirmation. Walensky will be the third woman to run the CDC. 

“Dr. Walensky is a fantastic appointment for head of the CDC for many reasons, not the least of which is her commitment to health equity,” said Ruth Faden, a bioethicist at Johns Hopkins University who focuses on immunizations for pregnant people. “We can expect a CDC under Dr. Walensky’s direction to be much more attuned to including the interests of women, including pregnant and lactating people, in all aspects of CDC operation.”

Walensky currently heads the infectious disease division at Boston-based Massachusetts General Hospital. She is known for her work on HIV/AIDS, particularly in addressing what kinds of treatments are most cost-effective. She has called for government regulation to bring down the price of many expensive drugs, spotlighting an issue that disproportionately affects women, who are more likely to forego medication because of cost barriers. Her appointment could steer the agency, which typically does not weigh in on drug pricing, to treat the issue as a public health concern rather than simply a cost one, said William Schaffner, an infectious disease expert at the Vanderbilt University School of Medicine.

Since the pandemic took hold this year, Walensky has written frequently about how to effectively respond to COVID-19, with her work prompting praise from other career scientists. 

“I am impressed with her background and credentials,” said Sonja Rasmussen, a 20-year CDC veteran and professor of pediatrics and epidemiology at the University of Florida. “I am pleased to see that she recognizes the many challenges that CDC is facing in the next steps related to the pandemic and that she plans to address them by focusing on the science.”

Walensky’s leadership could also help boost trust in an agency whose credibility, experts agree, has suffered over the past several months — especially since the CDC will play a critical role in encouraging people to actually take the coronavirus vaccine. Surveys suggest that currently, only a slim majority of Americans feel comfortable taking the vaccine, and that Black Americans are less likely to trust that it will be safe.

“She will be a wonderful public health communicator, and that’s so very important because during this COVID pandemic, we have not had as much clear, sustained communication as necessary,” Schaffner said. “It’s clear she and Dr. Tony Fauci [the director of the National Institute of Allergy and Infectious Diseases] will be on the same wavelength.”

Walensky’s COVID writings offer a window into how she might approach her position. For months, she has written in favor of more testing and other strategies to contain the virus. 

In a November study for the journal Health Affairs, she joined a group of researchers calling for the federal government to invest more money in distributing forthcoming coronavirus vaccines. The study stressed the need to make sure vaccines are accessible to “racial and ethnic minority groups among whom the effects of COVID-19 have been disproportionately felt.”

That holds particular weight as federal health experts, including the CDC, start to determine the order in which Americans will receive the first COVID-19 vaccines. Last week, a government advisory committee recommended that health care employees — a group that is 75 percent women — and nursing home residents be first in line. 

In the months to come, state governments will have to decide which groups take the next priority as they distribute more immunization doses. One such group would be essential workers, which represent about a third of working women and skews Black and Latina. Others include incarcerated people and immigrants. 

Under Walensky, the CDC could play a much larger role in steering vaccine distribution, and experts said that the agency under her direction is more likely to prioritize equity across race and gender. 

“Given her career and expertise, I assume she will make this a priority focus,” said Jennifer Kates, a senior vice president at the nonprofit Kaiser Family Foundation, who has collaborated with Walensky.

The emphasis on gender equity could extend beyond vaccine distribution. As a physician and researcher, Walensky co-authored an op-ed that criticized both the federal government and Gilead, a major pharmaceutical company, for failing to include women in the clinical trials for Descovy, an HIV prevention drug. 

“Equity and inclusion in clinical trial design are essential to scientific advancement, ensuring that the benefits of innovation and drug discovery safely reach everyone in need,” read the op-ed, which was published last December in the New England Journal of Medicine. 

In particular, the op-ed criticized the historic exclusion of women and pregnant people from large clinical trials, another theme of Walensky’s scholarship.

“That’s been very much a part of her career and vision,” said Chris Beyrer, an epidemiologist and AIDS researcher at Johns Hopkins University who has worked extensively with Walensky. “Particularly around the issues of gender she’s been a real leader of inclusion.”

That resonates now, he added, since the initial coronavirus vaccine candidates were all developed by companies that excluded pregnant people from their clinical trials. That has thrown a wrench in efforts to decide whether pregnant or breastfeeding people — especially those working in health care or other frontline positions — will be able to use the first batch of COVID vaccines. (Some companies are now starting to do their first major vaccine trials among pregnant people.)

Walenky’s selection, he said, is good news for efforts to correct that information gap, since her CDC will be responsible for tracking people’s long-term responses to the vaccine — including people who take it and come pregnant afterward.

“This is something that is going to be very important,” he said. “You want someone with the ethical expertise, the clinical expertise, the ability to lead to be managing that.”

Originally published by The 19th

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.